Lu-177-PSMA-R2

177Lu-PSMA-R2 was developed as patent protected equivalent of 177Lu-PSMA-617. This [...]

Lu-177-EB-PSMA-617

177Lu-EB-PSMA-617 is a PSMA-617 analogue developed in China as an [...]

Lu-177-DOTA-EB-TATE

177Lu-DOTA-EB-TATE is a theranostic agent based on octreotate that uses [...]

Lu-177-Debio-1124

177Lu-Debio 1124 is a second-generation radiolabeled peptide analogue of minigastrin [...]

Lu-177-CTT-1403

177Lu-CTT1403 is the therapeutic analogue of 18F-CTT1057, a phosphoramide based [...]

I-131-RPS-001

131I-RPS-001 (131I-MIP-1095) is a small radiolabeled molecule, a glutamate-urea-lysine analogue, [...]

I-131-Omburtamab

131I-Omburtamab (131I-Burtomab, 131I-8H9) is a monoclonal murine antibody, labeled with [...]

I-131-Naxitamab

131I-Naxitamab (131I-3F8) is a murine antibody targeting GD2 (disialoganglioside), labeled [...]

I-131-CAM-H2

131I-CAM-H2 (131I-SGMIB anti-HER2-VHH1; 131I-SGMIB) is a targeted radionuclide therapeutic drug [...]

Th-227-Anetumab

227Th-Anetumab (227Th-BAY2287411) is a mesothelin targeted thorium conjugate (MSLN-TTC) consisting [...]

Go to Top